Related Experiment Videos
Ancrod for coronary angioplasty
A J Pothoulakis1, S K Neerukonda, G Ansel
1Department of Internal Medicine, Medical College of Ohio, Toledo 43699, USA.
Texas Heart Institute Journal
|January 1, 1995
Abstract:
Anticoagulation in the form of intravenous heparin is used after coronary angioplasty to prevent thrombosis. Ancrod, a rapid-acting defibrinogenating agent, has been used in various clinical settings that require anticoagulation. We present the use of ancrod after percutaneous transluminal coronary angioplasty in a patients with heparin-induced thrombopathia.